Free Trial

Los Angeles Capital Management LLC Has $7.46 Million Stock Position in The Clorox Company (NYSE:CLX)

Los Angeles Capital Management LLC raised its holdings in The Clorox Company (NYSE:CLX - Free Report) by 41.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 52,340 shares of the company's stock after acquiring an additional 15,344 shares during the quarter. Los Angeles Capital Management LLC's holdings in Clorox were worth $7,463,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in CLX. Vanguard Group Inc. boosted its holdings in Clorox by 0.3% during the third quarter. Vanguard Group Inc. now owns 15,341,234 shares of the company's stock worth $2,010,622,000 after buying an additional 44,344 shares in the last quarter. FMR LLC boosted its stake in shares of Clorox by 17.4% during the 3rd quarter. FMR LLC now owns 2,415,054 shares of the company's stock worth $316,517,000 after acquiring an additional 357,964 shares in the last quarter. Stifel Financial Corp grew its holdings in shares of Clorox by 2.2% in the 3rd quarter. Stifel Financial Corp now owns 2,184,875 shares of the company's stock worth $286,356,000 after acquiring an additional 47,879 shares during the period. Morgan Stanley increased its stake in Clorox by 1.8% in the 3rd quarter. Morgan Stanley now owns 1,738,928 shares of the company's stock valued at $227,904,000 after purchasing an additional 30,902 shares in the last quarter. Finally, Northern Trust Corp boosted its position in Clorox by 2.7% during the third quarter. Northern Trust Corp now owns 1,633,624 shares of the company's stock worth $214,103,000 after purchasing an additional 42,352 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.


Wall Street Analyst Weigh In

Several research analysts have recently issued reports on CLX shares. Evercore ISI cut their price target on Clorox from $145.00 to $142.00 and set an "underperform" rating for the company in a research note on Wednesday. The Goldman Sachs Group assumed coverage on shares of Clorox in a research note on Friday, March 1st. They set a "sell" rating and a $140.00 price objective for the company. DA Davidson reaffirmed a "neutral" rating and issued a $162.00 target price on shares of Clorox in a research note on Wednesday, April 17th. JPMorgan Chase & Co. dropped their price target on Clorox from $159.00 to $158.00 and set a "neutral" rating for the company in a research report on Wednesday. Finally, Morgan Stanley reaffirmed an "equal weight" rating and set a $160.00 price objective on shares of Clorox in a research note on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. According to MarketBeat.com, Clorox presently has an average rating of "Hold" and a consensus target price of $146.43.

View Our Latest Analysis on CLX

Clorox Trading Down 1.0 %

Shares of Clorox stock traded down $1.44 during trading hours on Friday, hitting $138.23. The company's stock had a trading volume of 2,036,238 shares, compared to its average volume of 1,340,454. The company has a quick ratio of 0.57, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The company has a market capitalization of $17.17 billion, a PE ratio of 71.62, a P/E/G ratio of 2.16 and a beta of 0.44. The business has a fifty day moving average of $148.45 and a 200 day moving average of $143.43. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $176.24.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period last year, the company posted $1.51 earnings per share. The firm's revenue was down 5.3% compared to the same quarter last year. As a group, equities analysts forecast that The Clorox Company will post 5.83 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a yield of 3.47%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox's dividend payout ratio is presently 248.71%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should you invest $1,000 in Clorox right now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Featured Articles and Offers

Search Headlines: